Month: August 2020

WOBURN, Mass. and GIBSON CITY, Ill., Aug. 11, 2020 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has signed a three-year non-exclusive research agreement with GDM (“GDM”), a company specialized in plant genetics based in Gibson City, Illinois to evaluate novel yield traits in soybean.Under the agreement, GDM plans to work with Yield10 yield traits within its research and development program for soybean as a strategy to improve soybean yield performance and sustainability.  The research agreement includes three novel crop yield traits in the first phase with the potential to expand the program to more traits in the future. In greenhouse and/or field tests performed by Yield10 to date, these novel traits have shown a range of promising activities relevant to...

MILTON, N.Y., Aug. 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Sono-Tek Corporation (OTCQX: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has submitted an application to uplist its common stock to the NASDAQ Capital Market.Dr. Christopher L. Coccio, CEO and Chairman of Sono-Tek, commented, “Sono-Tek has a strong financial base, has demonstrated excellent revenue growth and maintains a positive outlook for continued expansion, making this an opportune time to apply to uplist the Company’s shares to the NASDAQ Capital Market. We believe that this transition will increase corporate visibility, improve our stock’s trading liquidity, and broaden awareness of Sono-Tek in the investment community. If successful, this action would mark a return to NASDAQ for Sono-Tek which traded...

WARREN, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, announced today that it has appointed Wassim Fares, M.D., MSCR, as Chief Medical Officer.“We are thrilled to welcome Wassim, a seasoned industry leader, to Bellerophon to lead our clinical development at such an important time for the company,” said Fabian Tenenbaum, Chief Executive Officer of Bellerophon. “Wassim’s deep cardiopulmonary disease expertise as a pulmonologist and principal clinical trial investigator will prove critical to Bellerophon as we advance our two late-stage INOpulse® programs in Pulmonary Hypertension associated with Pulmonary Fibrosis (PH-PF) and COVID 19, as well...

LOWELL, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — CSP Inc. (NASDAQ: CSPI), a provider of security and packet capture products, managed IT and professional services and technology solutions, reported financial and operating results for the 2020 fiscal third quarter ended June 30, 2020 and provided a business update.Fiscal Third Quarter Highlights and Recent DevelopmentsImproved gross margin percentage by 9% compared to the year-ago fiscal third quarter, driven by primarily higher margin products.The ARIA Cybersecurity Solutions product pipeline has grown and Unified-Communications-as-a-Service (UCaaS) added several customers, highlighting the continued interest and demand for its feature-rich functionality.Expanded in our managed service practice, including cloud, Office 365 and other Microsoft offerings.In early April when it became...

LAS VEGAS, Aug. 11, 2020 (GLOBE NEWSWIRE) — Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that within the past several days it has begun to push critical updates to the Company’s Psychedelic Spotlight website (www.psychedelicspotlight.com) in an effort to more effectively align the site with the growth initiatives and strategies it has established, and infusing it with features intended to optimize potential revenue generation capabilities over the next several months.The Company contends that some of the most significant updates to the site were made to its homepage where its objective was to provide a more intuitive layout designed to magnify news headlines within the emerging space of psychedelic medicine, along with its own original industry-based content, and encourage...

ISLAND PARK, N.Y., Aug. 11, 2020 (GLOBE NEWSWIRE) — Global Diversified Marketing Group Inc (OTC: GDMK) reported results for its second fiscal quarter ended June 30th, 2020.Highlights for the three months ended June 30th, 2020 were as follows:Revenues were $253,341 for the 2020 period compared to $418,638 during the same three months ended June 30th, 2019 while most of the quarter has been shut down.Excluding a one-time $120,000 non-cash charge for stock-based compensation relating to stock issuance, operating expenses were $124,800 compared to $141,455 in the prior period.For the six months ended June 30th, 2020, after excluding stock-based compensation, the Company’s operating loss was $51,232 compared to $53,389 in the prior year.Secured New Distribution with over 350 Grocery Outlet LocationsSigned an Agreement with AATAC to Expand...

Tampa, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to announce the Company’s new B2 Fighting Series LIVE Event Fall Season Schedule, packed with thirteen (13) top events representing a mix of Fighting and Grappling showcases set to take place in ten major metropolitan markets across five top fighting states.With its new Fall Event Season – including a 30% increase in events on a year-over-year basis – the B2Digital B2 Fighting Series continues to establish itself as the Premier Development League for the MMA marketplace.Due to the COVID-19 outbreak, the Company’s Spring and Summer 2020 event seasons were suspended. However, B2Digital is extremely excited to offer up an...

– NCCN Guideline Updates Highlight Need for Maximum CIN Prevention and Resource Allocation for COVID-19 Patients –– First Patient Dosed in the U.S. Avoided Grade 4 Neutropenia in Cycle 2 with Plinabulin and Pegfilgrastim, Despite Experiencing Grade 4 Neutropenia in Cycle 1 with Pegfilgrastim Alone –NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that the Company has initiated an Expanded Access Program (EAP) to enable doctors across the U.S. to use BeyondSpring’s late-stage asset, Plinabulin, to prevent cancer patients’ chemotherapy-induced neutropenia (CIN), both alone and in combination with G-CSFs (the current standard...

MINNEAPOLIS, Aug. 11, 2020 (GLOBE NEWSWIRE) — Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today provides a business update and reports financial results for the quarter ended June 30, 2020. The second quarter of 2020 was marked by meaningful corporate, financial and clinical progress.HighlightsNew CEO appointed on July 15, 2020Enrollment in clinical trial of SBP-101 has resumed, after temporary, Covid-19 related pauseFast Track designation received for SBP-101Additional funds raised through sale of equity securitiesCEO AppointmentIn July, the company appointed of Jennifer K. Simpson, PhD, MSN, CRNP as President and Chief Executive Officer and as a member of the Board of Directors. Dr. Simpson brings more than...

FARMINGTON HILLS, Mich., Aug. 11, 2020 (GLOBE NEWSWIRE) — Level One Bancorp, Inc. (“Level One” or the “Company”) (Nasdaq: LEVL), the holding company for Level One Bank (the “Bank”), announced today that it has priced an underwritten public offering of 1,000,000 depositary shares (the “depositary shares”), each representing a 1/100th interest in a share of 7.50% Non-Cumulative Perpetual Preferred Stock, Series B, no par value, with a liquidation preference of $2,500 per share (equivalent to $25.00 per depositary share).  In connection with the offering, the Company has granted the underwriters an option for 30 days to purchase up to an additional 150,000 depositary shares. The Company has applied to list the depositary shares on The Nasdaq Global Select Market under the symbol “LEVLP.” The offering is subject to customary closing...